Stefanie Heilmann-Heimbach Selected Research

Stefanie Heilmann-Heimbach Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2017
5	Genetic Risk Score 11/2023 - 01/2016
5	Alopecia (Baldness) 01/2022 - 04/2016
3	Inflammation (Inflammations) 12/2023 - 10/2017
3	Dementia (Dementias) 11/2023 - 01/2019
3	Cognitive Dysfunction 01/2023 - 01/2016
3	Schizophrenia (Dementia Praecox) 11/2022 - 10/2017
3	Neoplasms (Cancer) 01/2022 - 01/2018
2	Angioedema 01/2024 - 01/2022
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2023 - 11/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2018
2	Alcoholism (Alcohol Abuse) 10/2018 - 01/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	COVID-19 11/2022
1	Respiratory Insufficiency (Respiratory Failure) 11/2022
1	Hereditary Angioedemas 01/2022
1	Tics (Tic) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Emergence Delirium 10/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Diabetes Mellitus 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Congenital Diaphragmatic Hernias 07/2018
1	Pulmonary Hypertension 07/2018
1	Lung Diseases (Lung Disease) 07/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Multiple Sclerosis 01/2018
1	Mental Disorders (Mental Disorder) 10/2017
1	Rare Diseases (Rare Disease) 01/2017

Drug/Important Bio-Agent (IBA)

6	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2016
3	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 11/2023 - 11/2022
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2018
3	AndrogensIBA 01/2022 - 04/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024 - 01/2022
2	BradykininIBA 01/2024 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2017
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 07/2018 - 01/2017
2	ApolipoproteinsIBA 05/2018 - 01/2016
1	LithiumIBA 12/2023
1	Immunologic Factors (Immunomodulators)IBA 12/2023
1	Amyloid beta-PeptidesIBA 11/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 10/2021
1	sharpinIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	LipidsIBA 01/2019
1	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2018
1	CytokinesIBA 07/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	Ginkgo biloba extract (Rokan)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Factor VII (Proconvertin)IBA 10/2017
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 10/2017
1	Protein SIBA 10/2017
1	von Willebrand FactorIBA 10/2017
1	Blood Proteins (Serum Proteins)IBA 10/2017
1	Chromogranin AIBA 10/2017
1	Cystatin CIBA 10/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2017
1	Interferon-gamma (Interferon, gamma)IBA 10/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2016

Therapy/Procedure

1	Therapeutics 01/2022
1	Transplantation 10/2020